Skip to content
OpenCapital
Get started

Cytek Biosciences, Inc. CTKB Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$44.1MMiss by $98.3K
EPS-$0.12Miss by $0.04
Revenue estimate$44.2M
EPS estimate-$0.08

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$47.3M
EPS estimate-$0.02

Financials

Q1 2026

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$569.52M+19.9%
Enterprise value$554.48M+32.7%
P/S2.8×+0.4×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%—
Net margin-36.2%—
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%—
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Segments

By geography

See full
EMEA$10.8M-6.9%
APAC$7.8M-12.8%
Other$1.2M-50.0%

By segment

See full
Reportable Segment$44.1M+6.5%

By product

See full
Service$15.4M+15.1%

Versus estimates

Revenue

Q1 2026$44.1MMiss by $98.3K
Q4 2025$62.1MBeat by $5.0MQ3 2025$52.3MMiss by $6.5MQ2 2025$45.6MMiss by $747.0KQ1 2025$41.5MMiss by $1.2MQ4 2024$57.5MMiss by $1.9M

Diluted EPS

Q1 2026-$0.12Miss by $0.04
Q4 2025-$0.01Beat by $0.01Q3 2025-$0.01Miss by $0.02Q2 2025$0.01Beat by $0.03Q1 2025-$0.09Miss by $0.05Q4 2024$0.07Beat by $0.02

Ask the moment Cytek Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cytek Biosciences, Inc. report Q1 2026 earnings?
Cytek Biosciences, Inc. (CTKB) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Cytek Biosciences, Inc.'s Q1 2026 revenue and EPS?
Cytek Biosciences, Inc. reported revenue of $44.1M and eps of $-0.12 for Q1 2026.
Did Cytek Biosciences, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $44.2M by $98.3K. EPS missed the consensus estimate of $-0.08 by $0.04.
How did Cytek Biosciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.5% from $41.5M a year earlier and eps declined 33.3% from $-0.09.
Where can I find Cytek Biosciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-211948) and the 10-Q periodic report (0001628280-26-032293) directly on SEC EDGAR. The filing index links above go to sec.gov.